MYSZ Fundamental Analysis - MY SIZE INC

Name: MY SIZE INC (MYSZ) Stock
Brand: MY SIZE INC
Rating: 4 (3 reviews)

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to MYSZ. MYSZ was compared to 285 industry peers in the Software industry. MYSZ scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MYSZ does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

MYSZ had negative earnings in the past year.

MYSZ had a negative operating cash flow in the past year.

In the past 5 years MYSZ always reported negative net income.

In the past 5 years MYSZ always reported negative operating cash flow.

1.2 Ratios

MYSZ's Return On Assets of -35.74% is on the low side compared to the rest of the industry. MYSZ is outperformed by 77.89% of its industry peers.

MYSZ's Return On Equity of -47.55% is on the low side compared to the rest of the industry. MYSZ is outperformed by 69.12% of its industry peers.

		Industry Rank	Sector Rank
ROA	-35.74%
ROE	-47.55%
ROIC	N/A

ROA(3y)-65.37%

ROA(5y)-90.51%

ROE(3y)-125.25%

ROE(5y)-153.85%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

MYSZ's Gross Margin of 39.64% is on the low side compared to the rest of the industry. MYSZ is outperformed by 74.74% of its industry peers.

MYSZ's Gross Margin has declined in the last couple of years.

The Profit Margin and Operating Margin are not available for MYSZ so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	39.64%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-26.17%

GM growth 5Y-9.6%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MYSZ does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for MYSZ has been increased compared to 1 year ago.

MYSZ has more shares outstanding than it did 5 years ago.

MYSZ has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -7.75, we must say that MYSZ is in the distress zone and has some risk of bankruptcy.

With a Altman-Z score value of -7.75, MYSZ is not doing good in the industry: 87.02% of the companies in the same industry are doing better.

A Debt/Equity ratio of 0.02 indicates that MYSZ is not too dependend on debt financing.

MYSZ's Debt to Equity ratio of 0.02 is fine compared to the rest of the industry. MYSZ outperforms 61.75% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.02
Debt/FCF	N/A
Altman-Z	-7.75

ROIC/WACCN/A

WACC9.55%

2.3 Liquidity

MYSZ has a Current Ratio of 3.89. This indicates that MYSZ is financially healthy and has no problem in meeting its short term obligations.

With an excellent Current ratio value of 3.89, MYSZ belongs to the best of the industry, outperforming 82.46% of the companies in the same industry.

A Quick Ratio of 2.55 indicates that MYSZ has no problem at all paying its short term obligations.

The Quick ratio of MYSZ (2.55) is better than 71.58% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.89
Quick Ratio	2.55

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 75.26% over the past year.

MYSZ shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.86%.

Measured over the past years, MYSZ shows a very strong growth in Revenue. The Revenue has been growing by 165.15% on average per year.

EPS 1Y (TTM)75.26%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%88.63%

Revenue 1Y (TTM)-31.86%

Revenue growth 3Y297.97%

Revenue growth 5Y165.15%

Sales Q2Q%1.36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y33.17%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year12.88%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MYSZ. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MYSZ. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for MYSZ!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MY SIZE INC

NASDAQ:MYSZ (10/27/2025, 8:00:02 PM)

Premarket: 1.18 -0.04 (-3.28%)

1.22

+0.04 (+3.39%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)03-27 2025-03-27/amc

Earnings (Next)N/A N/A

Inst Owners2.04%

Inst Owner Change0%

Ins Owners3.14%

Ins Owner Change0%

Market Cap4.27M

Revenue(TTM)6.78M

Net Income(TTM)-3525000

Analysts82.86

Price Target3.06 (150.82%)

Short Float %4.87%

Short Ratio0.57

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.63
P/FCF	N/A
P/OCF	N/A
P/B	0.58
P/tB	0.7
EV/EBITDA	N/A

EPS(TTM)-2.45

EYN/A

EPS(NY)-2.75

Fwd EYN/A

FCF(TTM)-0.95

FCFYN/A

OCF(TTM)-0.95

OCFYN/A

SpS1.94

BVpS2.12

TBVpS1.74

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-35.74%
ROE	-47.55%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	39.64%
FCFM	N/A

ROA(3y)-65.37%

ROA(5y)-90.51%

ROE(3y)-125.25%

ROE(5y)-153.85%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-26.17%

GM growth 5Y-9.6%

F-Score4

Asset Turnover0.69

Health

		Industry Rank	Sector Rank
Debt/Equity	0.02
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.89
Quick Ratio	2.55
Altman-Z	-7.75

F-Score4

WACC9.55%

ROIC/WACCN/A

Cap/Depr(3y)6.12%

Cap/Depr(5y)22.62%

Cap/Sales(3y)0.26%

Cap/Sales(5y)5.92%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)75.26%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%88.63%

EPS Next Y33.17%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-31.86%

Revenue growth 3Y297.97%

Revenue growth 5Y165.15%

Sales Q2Q%1.36%

Revenue Next Year12.88%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y27.87%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y51.31%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y51.63%

OCF growth 3YN/A

OCF growth 5YN/A

MY SIZE INC / MYSZ FAQ

What is the fundamental rating for MYSZ stock?

ChartMill assigns a fundamental rating of 2 / 10 to MYSZ.

Can you provide the valuation status for MY SIZE INC?

ChartMill assigns a valuation rating of 0 / 10 to MY SIZE INC (MYSZ). This can be considered as Overvalued.

Can you provide the profitability details for MY SIZE INC?

MY SIZE INC (MYSZ) has a profitability rating of 0 / 10.

What is the expected EPS growth for MY SIZE INC (MYSZ) stock?

The Earnings per Share (EPS) of MY SIZE INC (MYSZ) is expected to grow by 33.17% in the next year.

MY SIZE INC (MYSZ) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

MY SIZE INC / MYSZ FAQ

What is the fundamental rating for MYSZ stock?

Can you provide the valuation status for MY SIZE INC?

Can you provide the profitability details for MY SIZE INC?

What is the expected EPS growth for MY SIZE INC (MYSZ) stock?